ScholarLens Back to search
2001•Hainan yixueRequires access

THERAPEUTIC COMPARISION OF TRANSESOPHAGEAL ATRIAL PACING AND PROPAFENONE IN TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA

SU Zheta

Open publisher page 0 citations

Abstract

Objective: To compare the effects of transesophageal atrial pacing and propafenone in treatment of parasysmal supraventricular tachycardia(PSVT).Methods: 44 patients with PSVT were distributed in the group of transesophageal atrial pacing,PSVT were terminated by S 1S 1 overdriving suppression or S 1S 2 programmed ectopic stimulation. 46 patients with PSVT were in group of propafenone,70mg propafenone was injected into each patient,after 20～40 minutes,if PSVT was not be terminated,70mg propafenone would be injected again,maximum dose of propafenone was 210mg. Results: The effective rate of terminating PSVT by transesophageal atrial pacing and propafenone was 81.8% and 82.6% respectively,there was no significant difference between the two groups(P0.05). Conclusion: Transesophageal atrial pacing is safe and effective in treatment of PSVT,and has few adverse reactions.

About this research paper

What this paper is about

Objective: To compare the effects of transesophageal atrial pacing and propafenone in treatment of parasysmal supraventricular tachycardia(PSVT).Methods: 44 patients with PSVT were distributed in the group of transesophageal atrial pacing,PSVT were terminated by S 1S 1 overdriving suppression or S 1S 2 programmed ectopic stimulation. 46 patients with PSVT were in group of propafenone,70mg propafenone was injected into each patient,after 20～40 minutes,if PSVT was not be terminated,70mg propafenone would be injected again,maximum dose of propafenone was 210mg. Results: The effective rate of terminating PSVT by transesophageal atrial pacing and propafenone was 81.8% and 82.6% respectively,there was no significant difference between the two groups(P0.05). Conclusion: Transesophageal atrial pacing is safe and effective in treatment of PSVT,and has few adverse reactions.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To compare the effects of transesophageal atrial pacing and propafenone in treatment of parasysmal supraventricular tachycardia(PSVT).Methods: 44 patients with PSVT were distributed in the group of transesophageal atrial pacing,PSVT were terminated by S 1S 1 overdriving suppression or S 1S 2 programmed ectopic stimulation. 46 patients with PSVT were in group of propafenone,70mg propafenone was injected into each patient,after 20～40 minutes,if PSVT was not be terminated,70mg propafenone would be injected again,maximum dose of propafenone was 210mg. Results: The effective rate of terminating PSVT by transesophageal atrial pacing and propafenone was 81.8% and 82.6% respectively,there was no significant difference between the two groups(P0.05). Conclusion: Transesophageal atrial pacing is safe and effective in treatment of PSVT,and has few adverse reactions.

Key concepts: Propafenone, Medicine, Significant difference, Supraventricular tachycardia, Cardiology, Adverse effect, Paroxysmal supraventricular tachycardia, Anesthesia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
THERAPEUTIC COMPARISION OF TRANSESOPHAGEAL ATRIAL PACING AND PROPAFENONE IN TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA — Research Paper | ScholarLens